Heat Biologics Selected as One of Informa's 2015 Top 10 Immuno-Oncology...
(Source: Heat Biologics Inc) DURHAM, N.C., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ('Heat') (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient's...
View ArticleSpring Bank Pharmaceuticals Presents Positive Phase 1 Data on SB 9200 at the...
MILFORD, Mass., Nov. 16, 2015 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, today...
View ArticleGlobal Anti-Inflammatory Therapeutics Market 2014-2020 by Indication, Drug...
DUBLIN, Nov. 16, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8rkdpz/world) has announced the addition of the "World Anti-Inflammatory Therapeutics Market -...
View ArticleStartup with U-M Medical School technology goes public (University of...
(Source: University of Michigan Health System) ANN ARBOR, Mich. - Kura Oncology Inc., a clinical stage biopharmaceutical company that develops therapies for cancer patients, is now trading on the...
View ArticleJohnson & Johnson multiple myeloma drug wins accelerated OK
TRENTON, N.J. (AP) - A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple myeloma in patients who've failed prior therapies and...
View ArticleHeat Biologics Selected as One of Informa's 2015 Top 10 Immuno-Oncology...
DURHAM, N.C., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat") (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient's immune system against...
View ArticleMerck Announces Presentation of Phase 3 Results of Investigational...
(Source: Merck Canada Inc) 873e2286-eea9-4711-96a6-d4be85d53f3a.pdf News Release Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 Merck Announces...
View ArticleNew Sean N. Parker Autoimmune Research Laboratory Is Launched at UCSF $10...
SAN FRANCISCO, Nov. 17, 2015 /PRNewswire/ -- A $10 million gift from The Parker Foundation, founded by Silicon Valley entrepreneur and philanthropist Sean Parker, will establish a new research...
View ArticleThe Burden of Hepatitis C Now That it Can be Cured and the Cost of Curing...
SAN FRANCISCO, Nov. 16, 2015 /PRNewswire/ -- Jagpreet Chhatwal, PhD, presented two studies at the annual meeting of the American Association for the Study of Liver Diseases that addressed the burden of...
View ArticleNew Sean N. Parker Autoimmune Research Laboratory is Launched at UCSF (UCSF -...
(Source: UCSF - University of California, San Francisco) A $10 million gift from The Parker Foundation, founded by Silicon Valley entrepreneur and philanthropist Sean Parker, will establish a new...
View ArticleHalozyme To Expand With A Satellite Office In San Francisco Growing Biotech...
SAN DIEGO, Nov. 17, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced it will be expanding...
View ArticleProprietary anti-cancer drug candidates (Phylogica Limited)
(Source: Phylogica Limited) XX April 2010 Phylogica exceeds gold-standard for treatment of MYC-driven cancer More than 7 in 10 cancer cases depend on the mutant gene MYC for survival1. While recognised...
View ArticleSciClone To Present At 27th Annual Piper Jaffray Healthcare Conference On...
FOSTER CITY, Calif., Nov. 17, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview...
View ArticleMajor US doctors group urges ban on drug ads
Members of a major US medical association called Tuesday for a ban on advertising prescription drugs to consumers, saying the practice helps drive up prices and harms patient health. The American...
View ArticleHalozyme To Expand With A Satellite Office In San Francisco
SAN DIEGO, Nov. 17, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced it will be expanding...
View ArticlePrice controls on drugs discourage breakthroughs: Guest commentary
Researchers at UC San Diego and health centers across Los Angeles are testing a potential treatment for lupus, an autoimmune disease that afflicts 1.5 million Americans with pain, fatigue, rashes and...
View ArticleU.S. Food and Drug Administration Accepts for Priority Review the...
(Source: Bristol-Myers Squibb Company) PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY)today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing...
View ArticleGlobal drug spending to hit $1.4 trillion in 2020 - IMS
Nov 18 (Reuters) - Global spending on medicines will reach $1.4 trillion in 2020, driven by increased healthcare access in emerging markets and high-priced new drugs for cancer and other diseases,...
View ArticleMerck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy...
(Source: Pfizer Inc) DARMSTADT, Germany & NEW YORK--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, and Pfizer today announced that the US Food and Drug Administration (FDA) has granted avelumab*,...
View ArticleLigand Provides Highlights from Today’s Analyst Day Event (Ligand...
(Source: Ligand Pharmaceuticals Inc) Webcast available at www.ligand.com SAN DIEGO-- At an Analyst Day event held earlier today in New York City, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)...
View Article
More Pages to Explore .....